Joseph Stringer Stock Analyst Profile - Needham Research Coverage - Stocknear

Joseph Stringer

Stock Analyst at Needham

(5)
# 127
Out of 5,493 analysts
354
Total ratings
Success rate
Average return

23 Stocks

Name Action PT Current % Upside Ratings Updated
CDTX Cidara Therapeutics
Maintains: Strong Buy
74 100
90.5 10.5% 15 Sep 24, 2025
RNA Avidity Biosciences
Maintains: Strong Buy
60 65
42.95 51.34% 18 Sep 10, 2025
IONS Ionis Pharmaceutical...
Maintains: Strong Buy
55 70
64.09 9.22% 23 Sep 2, 2025
ALNY Alnylam Pharmaceutic...
Maintains: Strong Buy
377 478
446.4 7.08% 23 Jul 31, 2025
GILD Gilead Sciences
Upgrades: Buy
133
112.1 18.64% 7 Jul 25, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Strong Buy
72 95
99.16 -4.2% 25 Jul 9, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
22 22
24.14 -8.86% 23 Jul 1, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
28 28
11.78 137.69% 52 Jun 6, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
14 14
5.49 155.01% 18 May 22, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Hold
12 12
n/a n/a 20 May 16, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
16 11
3.37 226.41% 19 May 13, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
40 29
22.37 29.64% 20 May 7, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Hold
n/a
n/a n/a 6 May 6, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
90 90
33.98 164.86% 17 Apr 8, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Hold
n/a
n/a n/a 13 Mar 7, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Hold
10 10
1.52 557.89% 17 Mar 4, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Hold
n/a
n/a n/a 8 Nov 8, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Hold
n/a
n/a n/a 16 Jun 13, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Upgrades: Buy
37
21.05 75.77% 5 Jan 24, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Hold
n/a
n/a n/a 5 May 23, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
42 32
n/a n/a 1 May 13, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Hold
n/a
n/a n/a 1 Dec 13, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
32 18
14.07 27.93% 2 Aug 24, 2021